No abstract available
Keywords:
duvelisib; inhibiteur de PI3 kinase; leucémie lymphoïde chronique; lymphome folliculaire.
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Clinical Trials, Phase II as Topic
-
Drug Approval*
-
Drug Resistance, Neoplasm
-
Europe
-
Humans
-
Isoquinolines / therapeutic use*
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / mortality
-
Lymphoma, Follicular / drug therapy*
-
Lymphoma, Follicular / mortality
-
Phosphatidylinositol 3-Kinases / therapeutic use*
-
Purines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Recurrence
Substances
-
Antibodies, Monoclonal, Humanized
-
Isoquinolines
-
Purines
-
duvelisib
-
ofatumumab